Financhill
Back

Structure Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.

Structure Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 21.74 Buy
20-day SMA: 22.44 Sell
50-day SMA: 25.55 Sell
200-day SMA: 35.31 Sell
8-day EMA: 21.63 Buy
20-day EMA: 22.78 Sell
50-day EMA: 25.52 Sell
200-day EMA: 32.74 Sell

Structure Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 44.72 Sell
Chaikin Money Flow: 111531 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.03 - 25.33) Sell
Bollinger Bands (100): (24.42 - 35.84) Sell

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Structure Therapeutics Stock

Is Structure Therapeutics Stock a Buy?

GPCR Technical Analysis vs Fundamental Analysis

Sell
33
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy or a Sell?

Structure Therapeutics Stock Info

Market Cap:
1.2B
Price in USD:
21.79
Share Volume:
325.3K

Structure Therapeutics 52-Week Range

52-Week High:
62.74
52-Week Low:
19.39
Sell
33
Structure Therapeutics (GPCR) is a Sell

Structure Therapeutics Share Price Forecast

Is Structure Therapeutics Stock a Buy?

Fundamental Analysis of Structure Therapeutics

Is Structure Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.08 per share, and a decrease next year of $0.68 per share.

Technical Analysis of Structure Therapeutics

Should I short Structure Therapeutics stock?

* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.